Respiri Ltd (ASX: RSH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Respiri Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $34.98 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.06 billion
Earnings per share -0.007
Dividend per share N/A
Year To Date Return 10.00%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Respiri Ltd (ASX: RSH)
    Latest News

    No posts found.

    RSH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Respiri Ltd

    Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

    RSH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    24 Apr 2024 $0.03 $0.00 0.00% 766,913 $0.03 $0.03 $0.03
    23 Apr 2024 $0.04 $0.00 0.00% 368,421 $0.04 $0.04 $0.04
    22 Apr 2024 $0.04 $0.00 0.00% 141,534 $0.03 $0.04 $0.03
    19 Apr 2024 $0.03 $0.00 0.00% 318,775 $0.03 $0.03 $0.03
    18 Apr 2024 $0.03 $0.00 0.00% 15,625 $0.03 $0.03 $0.03
    17 Apr 2024 $0.03 $0.00 0.00% 110,534 $0.03 $0.03 $0.03
    16 Apr 2024 $0.04 $0.00 0.00% 1,234,878 $0.03 $0.04 $0.03
    15 Apr 2024 $0.03 $0.00 0.00% 140,000 $0.03 $0.03 $0.03
    12 Apr 2024 $0.03 $0.00 0.00% 52,024 $0.03 $0.03 $0.03
    11 Apr 2024 $0.03 $0.00 0.00% 187,584 $0.03 $0.03 $0.03
    10 Apr 2024 $0.03 $0.00 0.00% 1,381,326 $0.03 $0.03 $0.03
    09 Apr 2024 $0.03 $0.00 0.00% 51,771 $0.03 $0.03 $0.03
    08 Apr 2024 $0.03 $0.00 0.00% 358,075 $0.03 $0.03 $0.03
    05 Apr 2024 $0.03 $0.00 0.00% 303,030 $0.03 $0.03 $0.03
    04 Apr 2024 $0.03 $0.00 0.00% 3,928,656 $0.03 $0.03 $0.03
    03 Apr 2024 $0.03 $0.00 0.00% 612,012 $0.03 $0.03 $0.03
    28 Mar 2024 $0.03 $0.00 0.00% 464,048 $0.03 $0.03 $0.03
    26 Mar 2024 $0.03 $0.00 0.00% 631,600 $0.03 $0.03 $0.03

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Nov 2023 Nicholas Smedley Issued 400,147 $12,404
    Placement.
    21 Nov 2023 Nicholas Smedley Issued 800,294 $27,209
    Placement.
    01 Sep 2023 Marjan Mikel Cancelled 30,000,000 $930,000
    As advised by the company. Cancellation of options
    01 Sep 2023 Nicholas Smedley Cancelled 30,000,000 $930,000
    As advised by the company. Cancellation of options at election of director
    30 May 2023 Brian Leedman Buy 620,068 $22,942
    On-market trade.
    30 May 2023 Brian Leedman Buy 620,068 $229,425
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Marjan Mikel Executive DirectorChief Executive OfficerManaging Director Nov 2019
    Mr Mikel is a managing director and board member with a career spanning Australia, Europe and Japan, Marjan's focus has been in the healthcare industry, from pharmaceuticals and information services and technology to medical devices and sleep disorder solutions. He founded and subsequently sold Healthy Sleep Solutions after developing it into a business, with Resmed Ltd as a joint venture/shareholder partner.
    Mr Nicholas Smedley Executive ChairmanExecutive Director Oct 2019
    Mr Smedley is an Investment Banker and M&A Advisor, with 14 years of experience at UBS and KPMG. He has worked on M&A transactions in the UK, Hong Kong, China, and Australia with transactions ranging from the A$9bn defence of WMC Resources through to the investment of $65m into Catch.com.au. Nicholas currently oversees investments in the Property, Aged care, Technology and Medical Technology space. Key areas of expertise include M&A, Debt structuring, corporate governance and innovation.
    Dr Tamejiro (Tom) Takubo jr. Non-Executive Director Dec 2023
    Dr Takubo also holds the position of Executive Vice President of Provider Relations at West Virginia University (WVU)
    Health System where his clinical experience as a community-based Pulmonologist and Critical Care specialist provides
    strategic and practical insights into WVUHS clinical development direction and investments. He is responsible for
    helping build and manage new relationships and partnerships with external healthcare organizations and other
    businesses. He leads the development of innovative digital healthcare strategies for the organisation designed to
    introduce more effective, world leading healthcare aimed at improving patient health outcomes. WVUHS provides
    services throughout West Virginia, Ohio, Pennsylvania and Maryland and includes a network of hospitals with more
    than 1,800 beds and other health care institutions and services.
    Mr Justin Mouchacca Joint Company Secretary Jan 2024
    -
    Ms Nova Taylor Joint Company Secretary Jan 2024
    -
    Theo Antonopoulos Chief Commercial Officer
    -
    Peter Hildebrandt Chief Operating Officer
    -
    Samaneh Sarraf Shirazi Chief Research Officer
    -
    George Vlachodimitropoulos Chief Technology Officer
    -
    Justin Mouchacca Joint Company Secretary
    -
    Nova Taylor Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Netwealth Investments Limited <Wrap Services A/C> 46,404,629 4.77%
    Netwealth Investments Limited <Super Services A/C> 37,234,965 3.82%
    Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C> 36,870,324 3.79%
    Citicorp Nominees Pty Ltimited 20,950,208 2.15%
    Mallamanda Pty Ltd <Mallamanda A/C> 18,032,352 1.85%
    Mr Peter Karl Braun 18,026,140 1.85%
    Mrs Tara Marjorie Hill 15,191,689 1.56%
    Obsidian Global Gp Llc 14,314,150 1.47%
    Mr Simon Dumaresq and Dr Belinda Jackson <Dumason A/C> 12,265,193 1.26%
    Mr John Anthony Dell 10,500,000 1.08%
    Rosherville Pty Ltd <Ayton Super Fund A/C> 9,800,000 1.01%
    Hsbc Custody Nominees (Australia) Limited 9,276,059 0.95%
    Craft Law Pty Ltd <Forster Super Fund A/C> 8,329,712 0.86%
    Mr Andre Szarukan and Ms Rose Braniska <The A & R Super Fund A/C> 8,042,199 0.83%
    P & A Mihailou Pty Lts <Mihailou Family A/C> 7,989,056 0.82%
    Mr Paul Argentino <Ap Investment Fund A/C> 7,761,141 0.80%
    Mr Gary Ronald Heath and Mrs Melissa Louisse Heath <G & M Heath Superfund A/C> 7,586,260 0.78%
    Torres Investments Pty Ltd 7,424,070 0.76%
    Clemwell Pty Ltd <The Wells Family A/C> 7,135,678 0.73%
    Dl Marshall Super Pty Ltd <Marshall Super Fund A/C> 7,000,000 0.72%

    Profile

    since

    Note